Digital Pathology News

Positive results on Immunoscore® in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France cohort study have been presented at ASCO 2019 HalioDx SAS, an immuno-oncology company pioneering the immunological...

Webinar | Proposed Changes to the Medicare Physician Fee Schedule and Quality Payment Program: What You Need to Know to Protect Your Lab’s Revenue and Preserve Profitability Moved to August 8th @ 1 PM EDT Register Now or Download...

NOTICE OF PUBLIC FORECLOSURE SALE NOTICE IS HEREBY GIVEN that on July 11, 2019, at 10:00 AM Prevailing Eastern Time (the “Date of Sale”) at the offices of Sullivan & Worcester LLP, 1633 Broadway, New York, NY 10019, GPB Debt Holdings...

CIO Applications recently sat down with our founder and CEO Michael Grunkin. The technology print magazine focuses on usage of various tech start ups. In the latest issue the spotlight was placed on the marketplace of machine learning...

Date: June 27, 2019 Register Sullivan Nicolaides Pathology pursued an assessment over two years examining the viability of introducing digital pathology into their organization. Four commercially available scanners were evaluated against...

In many industries, there is standard 80/20 rule, which dictates that 80 percent of your time will be spent on 20 percent of your work. The remaining 80 percent of your work takes only 20 percent of your time. In medicine in general - and in...